[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"EuMelaReg gGmbH\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":38},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":26,"whyStopped":4,"lastUpdateSubmitDate":27,"lastUpdatePostDateStruct":28,"startDateStruct":31,"completionDateStruct":33,"leadSponsor":35,"locationsCount":5},"100496195","outcome-research-of-a-european-registry-platform-on-real-world-treatment-data-of-patients-with-advanced-nmsc-100496195",false,"NCT05741073","Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC","Inclusion Criteria:\n\n1. Patients aged ≥18 years at index date\n2. Patients documented in the European NMSC-registry fulfilling EMR quality standard\n3. Patients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting OR Patients with advanced cSCC who are not candidates for curative surgery\u002Fradiation in routine clinical practice (Cohort 2) OR Patients with advanced BCC who are not candidates for curative surgery\u002Fradiation in routine clinical practice (Cohort 3)\n\nExclusion Criteria:\n\n1\\. Patients receiving treatment within a clinical trial.","ALL","18 Years",{"count":18,"type":19},1300,"ESTIMATED","5 Years","OBSERVATIONAL","This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC\u002FBCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.",[24,25],"Basal Cell Carcinoma","Cutaneous Squamous Cell Carcinoma","RECRUITING","2025-03-10",{"date":29,"type":30},"2025-03-12","ACTUAL",{"date":32,"type":30},"2023-06-30",{"date":34,"type":19},"2027-12",{"name":36,"class":37},"EuMelaReg gGmbH","INDUSTRY",""]